Drug research

AK112 Injection

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Carboplatin; Pemetrexed

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Phase III Study of AK112 for NSCLC PatientsNCT06396065	Summit Therapeutics	Phase 3	Active not recruiting	2025-04-12Actual

Summit TherapeuticsActive not recruitingPrimary completion: 2025-04-12 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.